The moment in which we live is not pursuing the historical trajectory. Therefore, the " Science " (Science) magazine each year once the technological advances (Breakthrough of the Year) will always cause a lot of controversy, and even lead to some people's anger. Immune therapy is a cancer designed to activate the body's immune system, hoping to rely on their immune function to kill cancer cells and tumor tissue of a therapy, when we are highly publicized anti-cancer immune therapy, in fact, there are some risks because the ultimate effect of this therapy who do not know much now. When suspected journal "Science" now put this involves only a small number of cancer patients, but also can provide assistance to this group of people in a small part of the new technology as technological advances for the year, it will not have irresponsible? What is the true meaning of their annual Top Technology progress is it?

Final " Science " magazine still believes that the immune anticancer therapy should be selected. Because clinical trials conducted this year have confirmed the efficacy of this therapy, but also to dispel all doubts and speculation. Widely circulated stories about a variety of anti-cancer immune therapy, such as there was a woman suffering from lung cancer, tumors have been there grapefruit (grapefruit) so big, but she has lived a healthy 13 years; another 6 -year-old Unfortunately, children suffering from leukemia, almost would have been dead, and now he has a grade 3 and that his condition has gradually ease; Another kidney cancer metastasis, his condition is still a step by step improvement after stopping treatment.

When combining these anecdotal and scientific data, we doubt gradually dissipated. Immunotherapy has gradually become a different, a new anti-cancer, anti-cancer therapies with a variety of different past, which is not a target for tumor cells and tissues, but the body's own immune system. Oncologists this very "real " groups that the new situation is already open, open the bow is no turning back.

Translational Treatments arrived at this time, we can easily also study a lot of helpful knowledge via immunological therapy success stories - that's ready to isolation, perseverance to undertake research, just to lay an excellent ig4v1e4 as a way to have a very much better upcoming. Anticancer treatment commenced throughout cancer defense immunologist John Allison, he or she is currently with the College of Colorado Doctor Anderson Cancer Center (University or college involving Texas M . d . Anderson Cancer malignancy Heart within Dallas) perform. Back in the late 80s, french scientists seen in a Big t mobile surface area receptor protein, that they known as a cytotoxic T- lymphocyte antigen 4 (cytotoxic T-lymphocyte antigen Several), known as CTLA-4 when they didn't consider this and what's the connection between the tumour. Allison be located, CTLA-4 compound plays a role in To "brake" tissues, may are designed to prevent abnormal immune response. Therefore Allison speculate, In case you allow the braking system failure, is not allowing the particular defense mechanisms to address cancer tissue to submit that crazy?

However, this is just a speculation, there is no confirmed tests. After considering Allison, whom set up an analysis course, they believe the particular immune system is actually covered up throughout cancer malignancy individuals is paramount concern, and decided to curb the actual disease fighting capability is really a development fresh way to find cancers.

This is what passed for several years. CTLA-4 molecule is discovered in 1987, until finally 1996, Allison and additional personnel inside the "Science Inches (Science) magazine released articles. That they discovered that the particular fresh rodents against CTLA-4 antibody molecules can begin to play a role in cancer, your cancer inside these animals can easily fade away.